NINGBO INNO PHARMCHEM CO.,LTD. Logo
Home Contact Us
  1. Home
  2. Topic: Targeted Therapy

Products for Topic: Targeted Therapy

N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitr

N1-[2-(Dimethylamino)ethyl]-5-methoxy-N1-methyl-N4-[4-(1-Methyl-1H-indol-3-yl)-2-pyrimidinyl]-2-nitr

Vemurafenib

Vemurafenib

Osimertinib Mesylate

Osimertinib Mesylate

Larotrectinib

Larotrectinib

Sorafenib Free Base

Sorafenib Free Base

Crenolanib

Crenolanib

Cobimetinib

Cobimetinib

Mutated EGFR-IN-1

Mutated EGFR-IN-1

Broad-Spectrum Kinase Inhibitor

Broad-Spectrum Kinase Inhibitor

Calicheamicin

Calicheamicin

Ceritinib

Ceritinib

Ruxolitinib Phosphate

Ruxolitinib Phosphate

Sunitinib Malate

Sunitinib Malate

Brigatinib

Brigatinib

Olaparib

Olaparib

GSK-1120212

GSK-1120212

Lapatinib Ditosylate

Lapatinib Ditosylate

SBE 13 hydrochloride

SBE 13 hydrochloride

GSK2636771

GSK2636771

Ponatinib

Ponatinib

Lenvatinib Intermediate

Lenvatinib Intermediate

4(3H)-Quinazolinone, 5-fluoro-3-phenyl-2-[(1S)-1-(1H-purin-6-ylamino)propyl]

4(3H)-Quinazolinone, 5-fluoro-3-phenyl-2-[(1S)-1-(1H-purin-6-ylamino)propyl]

Binimetinib

Binimetinib

Ibrutinib

Ibrutinib

Start Your Journey to Higher Quality

Reach out to our technical specialists today for customized solutions, samples, and a detailed quote. We are excited to build a brilliant future together.

Send an Inquiry by Email

NINGBO INNO PHARMCHEM CO.,LTD.

Add: 163 Ruiqing Road,Ningbo Zhejiang 315000 China | Tel:+86 574 87319282 / 87314919

© 2025 All Rights Reserved.